Voyageur Pharmaceuticals Ltd. (VYYRF)
OTCMKTS · Delayed Price · Currency is USD
0.1301
0.00 (0.00%)
Jan 6, 2026, 9:30 AM EST
Voyageur Pharmaceuticals Market Cap
Voyageur Pharmaceuticals has a market cap or net worth of $22.61 million as of January 8, 2026. Its market cap has increased by 211.13% in one year.
Market Cap
22.61M
Enterprise Value
21.95M
Revenue
8.04K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.13
Market Cap Chart
Since March 10, 2017, Voyageur Pharmaceuticals's market cap has increased from 3.53M to 22.61M, an increase of 539.92%. That is a compound annual growth rate of 23.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 22.61M | 2.10% |
| Dec 31, 2025 | 22.14M | 142.28% |
| Dec 31, 2024 | 9.14M | 21.27% |
| Dec 29, 2023 | 7.54M | 1.58% |
| Dec 30, 2022 | 7.42M | 2.46% |
| Dec 31, 2021 | 7.24M | 58.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 10, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 781.81M |
| Glass House Brands | 714.29M |
| Elite Pharmaceuticals | 527.53M |
| Northwest Biotherapeutics | 499.37M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 368.24M |
| Silence Therapeutics | 280.10M |